We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PPC:ATHEXPublic Power Corporation S.A. Analysis

Data as of 2026-06-12 - not real-time

$29.66

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Pilgrim's Pride (PPC) is trading at $29.66, just above its 20‑day SMA of $28.68 but well below the 50‑day ($31.34) and 200‑day ($37.79) averages, indicating short‑term momentum yet a longer‑term bearish trend. The RSI sits near 50, suggesting neutral price pressure, while the MACD histogram is positive (+0.37) and the signal line is bullish, hinting at a possible technical rebound toward the $30.30 resistance level. Volatility is elevated at 41% over the past 30 days, but beta is exceptionally low (0.04), meaning the stock’s moves are largely idiosyncratic rather than market‑driven. Fundamentally, the company trades at a low P/E of 7.95 and P/B of 1.90, with a DCF‑derived fair value of $45.22, implying roughly 32% upside from current levels. However, margins are thin (gross 11.6%, operating 4.2%, profit 4.8%) and free cash flow is negative (-$0.9B), while leverage is high (debt‑to‑equity 89.6%). The balance sheet shows $3.35B of debt versus $0.54B cash, raising concerns about debt servicing. ROE remains strong at 25.8%, indicating efficient use of equity despite cash flow constraints. Analyst consensus is a “Buy” with a median price target of $37.50, and UBS has initiated coverage with a neutral stance but a high upside estimate. Upcoming Q1 earnings on April 30, 2026, could clarify the cash‑flow narrative and impact sentiment. Overall, the stock appears undervalued on valuation metrics but carries notable execution and liquidity risks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical bounce toward resistance with bullish MACD
  • Significant upside to DCF fair value
  • Increasing volume supporting price stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Low valuation multiples (P/E, P/B) relative to peers
  • Analyst price targets averaging $38‑$39
  • Strong ROE suggesting profitability if cash flow improves

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage and negative free cash flow remain concerns
  • Stable consumer‑defensive sector offering resilience
  • Potential regulatory and commodity price pressures in meat production

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin4.78%
P/E Ratio8.0
ROE25.81%
ROA9.31%
Debt/Equity89.62
P/B Ratio1.9
Op. Cash Flow$1.4B
Free Cash Flow$-900115520

Technical Analysis

TrendBearish
RSI50.1
Support$27.13
Resistance$30.30
MA 20$28.68
MA 50$31.34
MA 200$37.79
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value$45.22
Target Price$39.25
Upside/Downside32.33%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.04
Volatility41.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.